Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sezary Syndrome × mogamulizumab × Clear all

Status

Recruiting 3 Terminated 2 Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Sezary Syndrome 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Specimen Handling 2 Nivolumab 2 Lenalidomide 2 Biopsy 2 talimogene laherparepvec 1 romidepsin 1 pembrolizumab 1 mogamulizumab 1 fludarabine phosphate 1 fludarabine 1 duvelisib 1 durvalumab 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Radiotherapy 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05455931 2024-09-04

PROSPER

Kyowa Kirin Co., Ltd.

Active not recruiting

Mycosis Fungoides, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡